Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock
NCT01352182
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Severe Sepsis
Septic Shock
Interventions
DRUG:
Pioglitazone hydrochloride
Sponsor
Children's Hospital Medical Center, Cincinnati